Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
McKesson Corporation MCK
$389.07
-$2.96 (-0.76%)
На 18:00, 12 мая 2023
-15.91%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
53660919675.00000000
-
week52high
401.78
-
week52low
298.69
-
Revenue
263966000000
-
P/E TTM
16
-
Beta
0.58166000
-
EPS
21.77000000
-
Last Dividend
2.16000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 22 авг 2022 г. |
| Credit Suisse | Outperform | Outperform | 08 авг 2022 г. |
| UBS | Buy | Buy | 04 авг 2022 г. |
| Mizuho | Neutral | Neutral | 04 авг 2022 г. |
| Baird | Outperform | Outperform | 04 авг 2022 г. |
| Argus Research | Buy | Buy | 12 сент 2022 г. |
| Mizuho | Neutral | Neutral | 14 ноя 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 02 ноя 2022 г. |
| Baird | Outperform | Outperform | 02 ноя 2022 г. |
| Baird | Outperform | Outperform | 11 янв 2023 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Morgan Stanley | Overweight | Overweight | 02 февр 2023 г. |
| Baird | Outperform | Outperform | 02 февр 2023 г. |
| UBS | Buy | Buy | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Schechter Lori A. | D | 4178 | 2500 | 09 дек 2022 г. |
| Schechter Lori A. | D | 6678 | 2500 | 10 ноя 2022 г. |
| Faber Tracy | D | 0 | 2811 | 08 ноя 2022 г. |
| Faber Tracy | D | 0 | 90 | 08 ноя 2022 г. |
| Faber Tracy | D | 90 | 1853 | 08 ноя 2022 г. |
| Faber Tracy | D | 1943 | 868 | 08 ноя 2022 г. |
| Faber Tracy | A | 2811 | 2811 | 08 ноя 2022 г. |
| Faber Tracy | D | 963 | 879 | 08 ноя 2022 г. |
| Faber Tracy | D | 1842 | 1051 | 08 ноя 2022 г. |
| Faber Tracy | A | 2893 | 2893 | 08 ноя 2022 г. |
Новостная лента
McKesson Stock Approaching New Highs As Bullish Trend Continues
MarketBeat
12 мая 2023 г. в 07:11
McKesson Corp. NYSE: MCK is among the elite group of stocks breaking out of bases and approaching new highs. While there have been numerous breakouts recently, many are out of patterns forming well below multi-year highs; McKesson is within striking distance of its highest price ever.
McKesson (MCK) Q4 Earnings Beat Estimates, U.S. Sales Strong
Zacks Investment Research
09 мая 2023 г. в 07:38
McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.
2 Warren Buffett Stocks to Buy Hand Over Fist in May
The Motley Fool
09 мая 2023 г. в 05:45
Mastercard and McKesson both have solid growth profiles. They both have increased their dividend payouts.
McKesson Corporation (MCK) Q4 2023 Earnings Call Transcript
Seeking Alpha
08 мая 2023 г. в 20:36
McKesson Corporation (NYSE:MCK ) Q4 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Nicole Kramer - Manager, Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Eric Percher - Nephron Research Michael Cherny - Bank of America Lisa Gill - JPMorgan Brian Tanquilut - Jefferies Charles Rhyee - TD Cowen Daniel Grosslight - Citi George Hill - Deutsche Bank Kevin Caliendo - UBS Steven Valiquette - Barclays Erin Wright - Morgan Stanley Elizabeth Anderson - Evercore ISI A.J. Rice - Credit Suisse Operator Welcome to McKesson's Fourth Quarter Fiscal 2023 Earnings Conference Call.
McKesson (MCK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research
08 мая 2023 г. в 19:45
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.